Drawing for TARGET HEALTH INC

USPTO serial 77913948

TARGET HEALTH INC

Reviewed by CopyMark Law Group

Reg. 4218213Status 710
Filing date
Status date
Registration date
Oct 2, 2012
Examiner
LORENZO, KATHLEEN H
Law office
TMEG LAW OFFICE 109

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with TARGET HEALTH INC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kenneth I. Kohn

KENNETH I. KOHN KOHN & ASSOCIATES, PLLC30500 NORTHWESTERN HWY STE 410FARMINGTON HILLS, MI 48334-3179UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Data processing; Providing statistical information for business or commercial purposes; Business auditing services; data processing services in the biostatistics field; Performing statistical analysis for business or commercial purposes; manufacturer representatives in the field of pharmaceuticals; development of business processes for the analysis and implementation of clinical trials dealing with pharmaceutical drug developmentSECTION 8 - CANCELLEDApr 28, 2012
042Providing online computer database for use in gathering and providing clinical trials data regarding medical and scientific research; Scientific research; Research in the medical and pharmaceutical fields; Product research and development; medical and scientific research services in the field of treatment and diagnosis provided for medical service providers; Technical writing for others; Providing quality assurance services in the field of pharmaceuticals; troubleshooting of product and process development problems dealing with safety and regulatory toxicology programs as it relates to medical and scientific research in the development of pharmaceutical drugs; Medical and scientific research, namely, conducting clinical trials; Consultation in the fields of pharmaceutical drug development, namely, conducting clinical trials; consultation in the fields of pharmaceutical drug development, namely, consulting with sponsor, medical, scientific, toxicology, manufacturing and business experts to clearly delineate development requirements and evaluate available and competitive technologies; Development of pharmaceutical product processes for others; Technical writing for others, namely, writing integrated clinical and statistical study reports and regulatory manuscripts related to medical and scientific research in the development of pharmaceutical drugs, as an integrated component; compiling patient records and patient data via a global computer information network for research purposes in the field of medical science and medical consultancySECTION 8 - CANCELLEDApr 28, 2012
045Reviewing standards and practices to assure compliance with medical and pharmaceutical laws and regulations; reviewing standards and practices to assure compliance with US Food and Drug Administration (FDA) laws and regulations; legal consulting services regarding Food and Drug law and regulation compliance, namely, consulting in the preparation of legal negotiations, in the preparation of legal documents and forms required by the FDA, in the preparation of responses to FDA questions and warning letters, and the follow-up with FDA on post application submission questions, in the preparation of meetings with legal counsel; intellectual property licensing in the fields of drug, drug product, pharmaceutical and pharmaceutical productsSECTION 8 - CANCELLEDApr 28, 2012

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 14, 2023CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Oct 2, 2021REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Aug 12, 2020ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Sep 24, 2018NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Sep 24, 2018C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Sep 24, 2018APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 13, 2018E815TEAS SECTION 8 & 15 RECEIVED—
Sep 13, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 2, 2017REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 2, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 31, 2012SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED—
Aug 30, 2012SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Aug 29, 2012REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Aug 29, 2012CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 7, 2012SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jun 14, 2012IUAFUSE AMENDMENT FILED—
Jun 14, 2012EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Dec 2, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 1, 2011EX2GSOU EXTENSION 2 GRANTED—
Nov 29, 2011EXT2SOU EXTENSION 2 FILED—
Nov 29, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 29, 2011TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 22, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED—
Jun 16, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 15, 2011EX1GSOU EXTENSION 1 GRANTED—
Jun 15, 2011AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 13, 2011EXT1SOU EXTENSION 1 FILED—
Jun 13, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 14, 2010NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 19, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 19, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 15, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 15, 2010ALIEASSIGNED TO LIE—
Sep 7, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 7, 2010XAECEXAMINER'S AMENDMENT ENTERED—
Sep 7, 2010GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 7, 2010GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 7, 2010CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 19, 2010GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 19, 2010GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 19, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 14, 2010DOCKASSIGNED TO EXAMINER—
Jan 23, 2010MDSCNOTICE OF DESIGN SEARCH CODE MAILED—
Jan 22, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 21, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance